炎症诱导的长链非编码RNA LINC00665通过激活PKR/NF-κB通路增强肝细胞癌恶性程度
该研究在肝细胞癌中鉴定出NF-κB信号激活诱导的长链非编码RNA LINC00665,其与双链RNA激活蛋白激酶(PKR)结合并增强其活化,阻止泛素/蛋白酶体降解以维持蛋白稳定性,形成NF-κB信号正反馈环路,促进肝癌细胞增殖,且LINC00665高表达患者预后更差。
要点
- LINC00665由NF-κB信号激活诱导,在肝细胞癌中形成炎症相关正反馈环路。
- LINC00665与PKR结合并增强其活化,维持PKR蛋白稳定性。
- LINC00665高表达与肝细胞癌患者较差预后相关,可能为潜在治疗靶点。
核心结论
- LINC00665参与肝细胞癌中NF-κB信号激活,炎症性LINC00665/PKR/NF-κB环路在肝癌进展中发挥致癌作用,可能为潜在治疗靶点。
研究设计与样本
- 研究在肝细胞癌中表征NF-κB信号激活诱导的LINC00665,并通过体外和体内实验评估其对肝癌细胞增殖的影响。
主要发现
- LINC00665与PKR物理相互作用,增强PKR活化,并通过阻断泛素/蛋白酶体依赖性降解维持PKR蛋白稳定性,导致NF-κB信号正反馈调节。
- LINC00665促进肝癌细胞在体外和体内的增殖。
- LINC00665较高的肝细胞癌患者临床预后较差。
临床怎么用
- LINC00665/PKR/NF-κB环路可能作为肝细胞癌的潜在治疗靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: The nuclear factor kappa B (NF-κB) signaling pathway is important for linking inflammation and tumorigenesis. Here, we characterized an NF-κB signaling activation-induced long intergenic noncoding (LINC) RNA in hepatocellular carcinoma (HCC), LINC00665, that contributes to the enhanced cell proliferation of HCC cells both in vitro and in vivo. APPROACH AND RESULTS: LINC00665 physically interacts with the double-stranded RNA (dsRNA)-activated protein kinase (PKR), enhances its activation, and maintains its protein stability by blocking ubiquitin/proteasome-dependent degradation, resulting in a positive feedback regulation of NF-κB signaling in HCC cells. Notably, patients with HCC and higher LINC00665 have poorer outcomes in the clinic. CONCLUSIONS: Our findings indicate that LINC00665 is involved in the NF-κB signaling activation in HCC cells and that the inflammatory LINC00665/PKR/NF-κB loop plays important oncogenic roles in hepatic cancer progression and may be a potential therapeutic target.
引用
- Ding J, Zhao J, Huan L, et al. Inflammation-Induced Long Intergenic Noncoding RNA (LINC00665) Increases Malignancy Through Activating the Double-Stranded RNA-Activated Protein Kinase/Nuclear Factor Kappa B Pathway in Hepatocellular Carcinoma. Hepatology. 2020. PMID: 32083756. doi:10.1002/hep.31195
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。